PT
Petros Pharmaceuticals, Inc.
PTPI · OTC
$0.01 +7.20% (+$0.00)
1M +11.11%
Market Cap $169.5K
P/E Ratio -
Div. Yield -
ROE 147.03%
Bulios Fair Price
$0.01
86.6% upside
Current Price
$0.0054
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PTPI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/B 0.24x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 456.00%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 484.80%
ROE 147.03%
ROA 90.30%
Debt
85 /100
Low Debt/Equity 0.00x
Current ratio 1.25x
Int. coverage N/A
Stability
33 /100
Unstable Beta 1.96x
Rev. volatility 53.60%
EPS volatility 9.67%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PTPI
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Fady Boctor
Employees
3
Headquarters
New York City
Upcoming events
02 DEC
Earnings
Upcoming earnings report